Biochip Labs provides blood disorder testing for conditions like sickle cell disease and thalassemia.
Biochip Labs has raised $150K in total funding. The most recent round was Grant. The last funding was announced in July 2023.
Biochip Labs's investors include National Science Foundation, Ohio Third Frontier.
Biochip Labs is headquartered in Cleveland, United States.
Biochip Labs provides blood disorder testing for conditions like sickle cell disease and thalassemia.
Biochip Labs is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biochip Labs — Funding & Investors." VCBacked, July 11, 2023, https://www.vcbacked.co/company/biochip-labs. Accessed November 14, 2026.
VCBacked. (2023). Biochip Labs — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/biochip-labs
{{cite web |title=Biochip Labs — Funding & Investors |url=https://www.vcbacked.co/company/biochip-labs |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Biochip Labs? Request a listing update